We also demonstrated that treatment with Pam2Cys promotes the development of influenza-specific adaptive immune responses that included IFN-γ, TNF-α, and IL-2 secreting CD8+ T-cells, which were found to persist in the lung up to 6 weeks after infection (30). Here, TNF is linked to influenza.